Journal
TRENDS IN IMMUNOLOGY
Volume 43, Issue 6, Pages 415-416Publisher
CELL PRESS
DOI: 10.1016/j.it.2022.04.006
Keywords
-
Categories
Funding
- Brigham Research Institute Pilot Award
Ask authors/readers for more resources
Research has shown that KIR+CD8(+) T cells in humans are similar to mouse Ly49(+)CD8(+) regulatory T cells and can kill pathogenic CD4(+) T cells, thereby suppressing autoimmune diseases and viral infections.
Mouse Ly49(+)CD8(+) regulatory T cells (Tregs) can subdue autoreactive CD4(+) T cells to suppress autoimmunity. Recently, Li et al. demonstrated that killer-cell immunoglobulin-like receptor (KIR)+CD8(+) T cells are the human equivalent of Ly49(+)CD8(+) regulatory T cells and kill pathogenic CD4(+) T cells, which can be increased in certain human autoimmune diseases and viral infections.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available